These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 16839851

  • 1. Differential effects of apolipoprotein E isoforms on lipolysis of very low-density lipoprotein triglycerides.
    Hara M, Iso-O N, Satoh H, Noto H, Togo M, Ishibashi S, Kimura S, Kadowaki T, Hashimoto Y, Tsukamoto K.
    Metabolism; 2006 Aug; 55(8):1129-34. PubMed ID: 16839851
    [Abstract] [Full Text] [Related]

  • 2. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD, Novoselov AV, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [Abstract] [Full Text] [Related]

  • 3. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J, Escolà-Gil JC, Rotllan N, Fiévet C, Vallez E, de la Torre C, Ribas V, Sloan JH, Blanco-Vaca F.
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE, Li X, van Dijk KW, Havekes LM, Zannis VI.
    Biochemistry; 2003 Aug 26; 42(33):9841-53. PubMed ID: 12924933
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.
    Tsukamoto K, Maugeais C, Glick JM, Rader DJ.
    J Lipid Res; 2000 Feb 26; 41(2):253-9. PubMed ID: 10681409
    [Abstract] [Full Text] [Related]

  • 7. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
    van Vlijmen BJ, van 't Hof HB, Mol MJ, van der Boom H, van der Zee A, Frants RR, Hofker MH, Havekes LM.
    J Clin Invest; 1996 Mar 01; 97(5):1184-92. PubMed ID: 8636429
    [Abstract] [Full Text] [Related]

  • 8. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y, Liu XQ, Rall SC, Mahley RW.
    J Biol Chem; 1998 Jul 10; 273(28):17483-90. PubMed ID: 9651338
    [Abstract] [Full Text] [Related]

  • 9. Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein.
    Sehayek E, Lewin-Velvert U, Chajek-Shaul T, Eisenberg S.
    J Clin Invest; 1991 Aug 10; 88(2):553-60. PubMed ID: 1864965
    [Abstract] [Full Text] [Related]

  • 10. The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice.
    Mensenkamp AR, Van Luyn MJ, Havinga R, Teusink B, Waterman IJ, Mann CJ, Elzinga BM, Verkade HJ, Zammit VA, Havekes LM, Shoulders CC, Kuipers F.
    J Hepatol; 2004 Apr 10; 40(4):599-606. PubMed ID: 15030975
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of transgenic mice to study the role of apolipoprotein E in lipid metabolism and atherosclerosis.
    Willems Van Dijk K, Hofker MH, Havekes LM.
    Int J Tissue React; 2000 Apr 10; 22(2-3):49-58. PubMed ID: 10937354
    [Abstract] [Full Text] [Related]

  • 13. [THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].
    Rozhkova TA, Titov VN, Amelyushkina VA, Kaba SI, Kukhartchuk VV.
    Klin Lab Diagn; 2015 Dec 10; 60(12):4-14. PubMed ID: 27032246
    [Abstract] [Full Text] [Related]

  • 14. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes.
    Kuipers F, Jong MC, Lin Y, Eck M, Havinga R, Bloks V, Verkade HJ, Hofker MH, Moshage H, Berkel TJ, Vonk RJ, Havekes LM.
    J Clin Invest; 1997 Dec 01; 100(11):2915-22. PubMed ID: 9389759
    [Abstract] [Full Text] [Related]

  • 15. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia.
    Huang Y, Liu XQ, Rall SC, Taylor JM, von Eckardstein A, Assmann G, Mahley RW.
    J Biol Chem; 1998 Oct 09; 273(41):26388-93. PubMed ID: 9756870
    [Abstract] [Full Text] [Related]

  • 16. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
    Ebara T, Ramakrishnan R, Steiner G, Shachter NS.
    J Clin Invest; 1997 Jun 01; 99(11):2672-81. PubMed ID: 9169497
    [Abstract] [Full Text] [Related]

  • 17. Apolipoprotein E2 (Lys146-->Gln) causes hypertriglyceridemia due to an apolipoprotein E variant-specific inhibition of lipolysis of very low density lipoproteins-triglycerides.
    de Beer F, van Dijk KW, Jong MC, van Vark LC, van der Zee A, Hofker MH, Fallaux FJ, Hoeben RC, Smelt AH, Havekes LM.
    Arterioscler Thromb Vasc Biol; 2000 Jul 01; 20(7):1800-6. PubMed ID: 10894820
    [Abstract] [Full Text] [Related]

  • 18. Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner.
    Jong MC, Dahlmans VE, Hofker MH, Havekes LM.
    Biochem J; 1997 Dec 15; 328 ( Pt 3)(Pt 3):745-50. PubMed ID: 9396715
    [Abstract] [Full Text] [Related]

  • 19. Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer.
    Liu G, Excoffon KJ, Wilson JE, McManus BM, Miao L, Benoit P, Duverger N, Branellec D, Denefle P, Hayden MR, Lewis ME.
    Clin Invest Med; 1998 Dec 15; 21(4-5):172-85. PubMed ID: 9800066
    [Abstract] [Full Text] [Related]

  • 20. Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E.
    Veinbergs I, Van Uden E, Mallory M, Alford M, McGiffert C, DeTeresa R, Orlando R, Masliah E.
    Exp Neurol; 2001 Jul 15; 170(1):15-26. PubMed ID: 11421580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.